Dilaudid (hydromorphone) is about 5 times stronger than morphine on a milligram-for-milligram basis. This ratio holds whether the drugs are taken by mouth or given by injection. So 1 mg of hydromorphone delivers roughly the same pain relief as 5 mg of morphine.
The 5-to-1 Potency Ratio
The standard conversion used in clinical practice is straightforward: 5 mg of oral morphine equals 1 mg of oral hydromorphone. The same 5:1 ratio applies when both drugs are given by injection. The CDC uses a morphine milligram equivalent (MME) conversion factor of 5.0 for hydromorphone, meaning every milligram of hydromorphone is counted as 5 milligrams of morphine for prescribing and risk-assessment purposes.
This doesn’t mean hydromorphone produces five times the “high” or five times the side effects. It means the doses are simply adjusted so that equivalent amounts produce similar levels of pain relief. A person prescribed 2 mg of hydromorphone is getting roughly the same analgesic effect as someone on 10 mg of morphine.
Why Hydromorphone Is More Potent
Two things explain the difference. First, hydromorphone binds more tightly to opioid receptors in the brain. When researchers rank opioids by how strongly they latch onto the mu-opioid receptor (the one responsible for pain relief, sedation, and euphoria), hydromorphone falls into the highest-affinity category, while morphine sits in a lower tier. Tighter binding at lower concentrations means less drug is needed to produce the same effect.
Second, hydromorphone is more fat-soluble than morphine. Because the brain is largely composed of fatty tissue, a more lipid-soluble drug crosses from the bloodstream into the brain faster and more efficiently. This is why hydromorphone not only requires a smaller dose but also tends to reach peak effect more quickly.
Speed and Duration
When given intravenously, hydromorphone begins working within about 5 minutes and hits peak effect in 8 to 20 minutes. Its pain relief lasts roughly 1 to 2 hours by that route. Taken by mouth, it kicks in within about 30 minutes and lasts 3 to 4 hours. Morphine follows a similar general timeline but is absorbed subcutaneously more slowly than hydromorphone because of the lipid-solubility difference. In a randomized trial comparing the two drugs given under the skin for cancer pain, hydromorphone was absorbed faster and crossed into the brain sooner.
How the Body Processes Each Drug
Both hydromorphone and morphine are absorbed somewhat unpredictably when swallowed. Oral bioavailability for hydromorphone ranges from about 10% to 65%, with wide variation from person to person. Morphine has a similarly broad range. This means the actual amount that reaches your bloodstream after an oral dose can differ substantially between individuals, which is one reason doctors often need to adjust doses over time.
Where the two drugs diverge more meaningfully is in how they’re broken down. Morphine is processed in the liver into two main byproducts. One of these, called M6G, is pharmacologically active: it contributes to pain relief but also to sedation and respiratory depression. Because M6G is cleared through the kidneys, it can build up dangerously in people with poor kidney function. This makes morphine a risky choice for anyone with kidney disease.
Hydromorphone’s main byproduct (H3G) is not active in the same way. It doesn’t provide additional pain relief or depress breathing the way morphine’s metabolite does. However, in people with very low kidney function (filtration rates below about 10), H3G can still accumulate and cause muscle twitching, confusion, or increased pain sensitivity. For most people with moderate kidney issues, though, hydromorphone is considered the safer option of the two.
Side Effects: Similar, Not Identical
Because both drugs work on the same receptor, they share the core opioid side effects: constipation, nausea, drowsiness, and the risk of slowed breathing at high doses. Clinical comparisons have found that the overall rate of side effects, including itching, is similar between the two when doses are adjusted to be equivalent. One pediatric study did suggest that some patients who experienced itching on morphine saw improvement after switching to hydromorphone, but this wasn’t universal. About a third of those patients continued to itch after the switch.
The practical takeaway is that switching from morphine to hydromorphone (or vice versa) doesn’t guarantee fewer side effects. The choice between them typically comes down to kidney function, individual response, and which formulation best fits a patient’s needs.
What the 5x Factor Means in Practice
If you’re being switched from one drug to the other, the conversion isn’t as simple as dividing or multiplying by five. Doctors typically reduce the calculated equivalent dose by 25% to 50% when switching between opioids, because individual biology means your response to a “new” opioid can be stronger than predicted. The oral-to-injectable conversion also matters: oral hydromorphone is roughly 2 to 3 times stronger than the same milligram amount given by mouth would suggest for injection, so switching routes requires its own dose adjustment.
The 5:1 ratio is a starting point for clinicians, not a precise universal truth. Your actual experience of pain relief and side effects depends on genetics, tolerance, kidney and liver function, and what other medications you’re taking.